ElendiLabs
KGMP 审查重点: 在 2026 年的审核中,TPA 将重点检查您的供应链追溯程序是否与韩国医用软件系统 (Medical Device Supply Record Reporting) 实时对接。 • 标签合规: 虽然 UDI 编码本身是全球通用的,但 KGMP 要求您的 QMS 必须包含一套针对“韩国标签定制”的受控程序。如果标签上缺少法定的韩语警告语,即使有 UDI,也会被判定为轻微不符合项 (Minor Non-conformity),必须在限定时间内整改。
Post your regulatory questions or request quotations from verified pharmaceutical consultants worldwide. Get matched with experts who specialize in your market.
April 26, 2024
Approximately 5 minutes
Korea Good Manufacturing Practice (KGMP) certification is a mandatory quality system requirement for foreign manufacturers seeking to register Class II, III, and IV medical devices with the Ministry of Food and Drug Safety (MFDS). KGMP compliance must be demonstrated in addition to, or leveraged through, international standards like ISO 13485.
The application for a KGMP Certificate must be submitted by the manufacturer's local importer in South Korea. The MFDS then determines the necessary audit scope.
The KGMP certification is a time-bound document that must be maintained to keep the device registration valid:
Government fees for the KGMP process vary significantly based on the level of audit required. Document audits have a lower associated fee compared to the more costly and time-consuming on-site audits, which are charged based on the number of audit days (e.g., 3-day, 4-day, or 5-day on-site audits).
We'll follow up with you personally.
ElendiLabs
KGMP 审查重点: 在 2026 年的审核中,TPA 将重点检查您的供应链追溯程序是否与韩国医用软件系统 (Medical Device Supply Record Reporting) 实时对接。 • 标签合规: 虽然 UDI 编码本身是全球通用的,但 KGMP 要求您的 QMS 必须包含一套针对“韩国标签定制”的受控程序。如果标签上缺少法定的韩语警告语,即使有 UDI,也会被判定为轻微不符合项 (Minor Non-conformity),必须在限定时间内整改。
Anonymous
我们的 AI 辅助诊断软件 (SaMD) 原计划按照传统的 KGMP 进行质量体系审核。但在 2026 年的监管框架下,听说软件类产品已从传统的 KGMP 规范中移除。现在我们需要遵循《数字医疗产品法》中的哪项特定质量管理要求?是否还需要进行传统的现场检查 (On-site Audit)?
ElendiLabs
根据 MFDS 第 2025-22 号通知,软件医疗器械 (SaMD) 的 KGMP 条款已正式移交给 《数字医疗产品法》(DMPA)。 新规重点: 您的质量管理体系 (QMS) 现在必须增加针对“网络安全”、“算法版本控制”以及“电子入侵预防”的特定程序。 审核形式: 对于纯软件产品,2026 年的审核趋向于全数字化文档审查。但如果您的产品涉及人工智能,必须额外提交符合 2026 年 1 月生效的 《人工智能基本法》 要求的“透明度与安全性验证”报告。
Anonymous
Our manufacturing facility in the US is already certified under MDSAP (Medical Device Single Audit Program). As of 2026, can we use our current MDSAP audit report to completely bypass the physical KGMP on-site inspection for our newly developed Class IV life-sustaining device? Are there any 'Korea-specific' annexes that must be included in the MDSAP report to satisfy the MFDS?
ElendiLabs
Scope of Waiver: While an MDSAP certificate is highly beneficial, it does not automatically bypass the on-site requirement for Class IV (highest risk) devices. For Class IV, the MFDS usually insists on a joint on-site inspection. However, for Class II and III devices, an MDSAP report conducted via a physical site visit can often transition your KGMP audit into a Desktop (Document) Review. • Specific Requirements: To be successful, your MDSAP audit report must be within its validity period and explicitly cover the manufacturing scope of the device you are registering in Korea. Most importantly, your QMS must demonstrate compliance with Article 31-2 (Vigilance Reporting) and other parts of the Korean Medical Devices Act, as these are "local requirements" that an international MDSAP audit might not fully detail.
Approximately 5 minutes
A guide to South Korea's medical device approval process via the MFDS, outlining the classification system, the requirement for Korean Good Manufacturing Practices (KGMP), and the expedited registration routes based on the existence of a Substantial Equivalent (S.E.).
Approximately 5 minutes
An overview of the South Korean MFDS registration for In-Vitro Diagnostic (IVD) devices, highlighting the GHTF-aligned classification, the role of predicate devices (S.E.) in accessing expedited third-party review for Class II, and the Safety and Efficacy Review (SER) route.
Approximately 5 minutes
Mandatory labeling for medical devices in South Korea is governed by the MFDS Medical Device Act. All labels, including the container and Instructions for Use (IFU), must be in Korean and contain specific identifiers like approval number, product name, and manufacturing data.
Approximately 5 minutes
An overview of South Korea's Post-Market Surveillance (PMS) requirements under the MFDS, covering mandatory tracking devices, adverse event reporting, and the severe administrative sanctions for non-compliance, including fines and license revocation.
Approximately 5 minutes
License maintenance in South Korea requires manufacturers to report any license amendments to the MFDS and comply with mandatory monthly supply reports for all device classes (Class IV to I) via the integrated information system, excluding home-use devices.
Anonymous
我们注意到韩国 2026 年对 II 类和 III 类器械的 UDI (唯一器械标识) 有了新的追溯要求。在 KGMP 审核中,审核员会如何检查我们的 UDI 系统?如果我们在海外工厂的包装线上仅贴有美国 FDA 标准的 UDI,是否会被视为 KGMP 的不符合项?